Problem Solving Therapy (PST) plus EUC for Suicidal Ideation

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto, CA
Suicidal Ideation
Problem Solving Therapy (PST) plus EUC - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The COVID-19 pandemic has led to increased caregiving demands for caregivers of Veterans with dementia. Dementia caregivers are particularly at-risk for depression and anxiety, known risk factors for increased suicidality. Emerging research also suggests that dementia caregivers are experiencing greater suicidality during COVID-19 at a time when VHA is also devoting increased efforts toward caregiver health and support services. Aims are to determine the feasibility and acceptability of video-delivered Problem-Solving Therapy for reducing suicide risk in caregivers of Veterans with dementia.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 1 Secondary · Reporting Duration: At study completion, up to 41 months or completed participation of all participants, whichever came first

At posttreatment (7 weeks)
Acceptability of treatment
Month 41
Appropriateness of inclusion/exclusion criteria
Feasibility of recruitment and retention of participants
Week 7
Sensitivity of trial outcome measures

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Active treatment plus EUC
1 of 1
Experimental Treatment

10 Total Participants · 1 Treatment Group

Primary Treatment: Problem Solving Therapy (PST) plus EUC · No Placebo Group · N/A

Active treatment plus EUC
Behavioral
Experimental Group · 1 Intervention: Problem Solving Therapy (PST) plus EUC · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: at study completion, up to 41 months or completed participation of all participants, whichever came first
Closest Location: VA Palo Alto Health Care System, Palo Alto, CA · Palo Alto, CA
Photo of california 1Photo of california 2Photo of california 3
2006First Recorded Clinical Trial
2 TrialsResearching Suicidal Ideation
53 CompletedClinical Trials

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,459 Previous Clinical Trials
2,748,903 Total Patients Enrolled
10 Trials studying Suicidal Ideation
2,203 Patients Enrolled for Suicidal Ideation
Sherry A Beaudreau, PhDPrincipal InvestigatorVA Palo Alto Health Care System, Palo Alto, CA

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are a caregiver to at least 1 older Veteran.
You have no evidence of dementia based on a negative cognitive telephone screen (<10 errors on the Blessed cognitive screen).
You have a score of 14 or lower on the AUDIT.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.